Pharma firm Gilead to raise Galapagos stake in $5.1 billion deal

(Reuters) - Gilead Sciences Inc will invest $5.1 billion (£4.06 billion) to increase its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.Gilead will receive an exclusive product license and option rights to develop and commercialize all current and future programs in countries outside Europe, according to a statement from the companies.The investment in Galapagos includes an..